{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:20Z","timestamp":1786119320682,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/md.0b013e3181b8bedc","type":"journal-article","created":{"date-parts":[[2009,9,8]],"date-time":"2009-09-08T03:12:49Z","timestamp":1252379569000},"page":"294-301","source":"Crossref","is-referenced-by-count":53,"title":["Resurgence of Pseudomonas Endocarditis in Detroit, 2006-2008"],"prefix":"10.1097","volume":"88","author":[{"given":"Milagros P.","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Biedenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210226","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-199411000-00003","article-title":"Pacemaker endocarditis. Report of 44 cases and review of the literature.","volume":"73","author":"Arber","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"R2-5-20210226","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-5223(19)39263-3","article-title":"Tricuspid valvulectomy without prosthetic replacement.","volume":"82","author":"Arbulu","year":"1981","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R3-5-20210226","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-5223(19)33944-3","article-title":"Tricuspid valvulectomy without replacement: twenty years' experience.","volume":"102","author":"Arbulu","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R4-5-20210226","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/106002809202600903","article-title":"Lack of in vitro inactivation of tobramycin by imipenem\/cilastatin.","volume":"26","author":"Ariano","year":"1992","journal-title":"Ann Pharmacother"},{"key":"R5-5-20210226","first-page":"e394","article-title":"Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America.","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"R6-5-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/infdis\/151.2.209","article-title":"Selective survival in pentazocine and tripelennamine of Pseudomonas aeruginosa seroype 011 from drug addicts.","volume":"151","author":"Botsford","year":"1985","journal-title":"J Infect Dis"},{"key":"R8-5-20210226","first-page":"96","article-title":"Tricuspid repair for infective endocarditis: clinical and echocardiographic results.","volume":"28","author":"Carozza","year":"2001","journal-title":"Tex Heart Inst J"},{"key":"R9-5-20210226","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/AAC.36.12.2577","article-title":"Continuous infusion of -lactam antibiotics.","volume":"36","author":"Craig","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-5-20210226","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of -lactams, glycopeptides, and linezolid.","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"R11-5-20210226","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/clinids\/8.3.364","article-title":"Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy.","volume":"8","author":"Crane","year":"1986","journal-title":"Rev Infect Dis"},{"issue":"Suppl 3","key":"R12-5-20210226","first-page":"S476","article-title":"Pathogenesis and treatment of endocarditis.","volume":"78","author":"Donabedian","year":"1985","journal-title":"Am J Med"},{"key":"R13-5-20210226","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/520991","article-title":"Back to the future: Using aminoglycosides again and how to dose them optimally.","volume":"45","author":"Drusano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R15-5-20210226","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000441-197603000-00008","article-title":"Characteristics of bacterial endocarditis in heroin addicts in Detroit.","volume":"271","author":"El-Khatib","year":"1976","journal-title":"Am J Med Sci"},{"key":"R16-5-20210226","first-page":"427","article-title":"Treatment of endocarditis due to Pseudomonas aeruginosa.","volume":"47","author":"Fichtenbaum","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R17-5-20210226","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.athoracsur.2007.05.093","article-title":"Invited commentary. An outstanding series of tricuspid valve operations for infective endocarditis.","volume":"84","author":"Gammie","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R18-5-20210226","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0732-8893(03)00135-4","article-title":"Left-sided endocarditis caused by Pseudomonas aeruginosa: successful treatment with meropenem and tobramycin.","volume":"47","author":"Gavin","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R20-5-20210226","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.athoracsur.2007.04.116","article-title":"Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis.","volume":"84","author":"Gottardi","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R21-5-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-199528020-00005","article-title":"The importance of pharmacokinetic\/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.","volume":"28","author":"Hyatt","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"R22-5-20210226","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/infdis\/154.1.64","article-title":"Failure of therapy in Pseudomonas endocarditis: selection of resistant mutants.","volume":"154","author":"Jimenez-Lucho","year":"1986","journal-title":"J Infect Dis"},{"key":"R24-5-20210226","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/clinids\/12.4.693","article-title":"Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center.","volume":"12","author":"Komshian","year":"1990","journal-title":"Rev Infect Dis"},{"key":"R25-5-20210226","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jac\/22.4.557","article-title":"Selection of resistance by piperacillin during Pseudomonas aeruginosa endocarditis.","volume":"22","author":"Letendre","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"R26-5-20210226","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinids\/8.3.374","article-title":"Bacteremia in narcotic addicts in the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study.","volume":"8","author":"Levine","year":"1986","journal-title":"Rev Infect Dis"},{"key":"R27-5-20210226","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R28-5-20210226","first-page":"575","article-title":"Six-year experience with cryopreserved mitral homografts in the treatment of tricuspid valve endocarditis in HIV-infected drug addicts.","volume":"8","author":"Mestres","year":"1999","journal-title":"J Heart Valve Dis"},{"key":"R29-5-20210226","first-page":"805","article-title":"Tricuspid valve replacement using a cryopreserved mitral homograft. Surgical technique and initial results.","volume":"9","author":"Miyagishima","year":"2000","journal-title":"J Heart Valve Dis"},{"key":"R30-5-20210226","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-147-12-200712180-00002","article-title":"Jr, and the International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK gram-negative bacillus endocarditis.","volume":"147","author":"Morpeth","year":"2007","journal-title":"Ann Intern Med"},{"key":"R31-5-20210226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/38.1.5","article-title":"Is continuous infusion of -lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations.","volume":"38","author":"Mouton","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"R32-5-20210226","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0022-5223(19)38264-9","article-title":"Earlier operation for left-sided endocarditis in drug addicts.","volume":"77","author":"Myerowitz","year":"1979","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R33-5-20210226","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jac\/dkh381","article-title":"Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.","volume":"54","author":"Navas","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"R34-5-20210226","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/infdis\/144.5.482","article-title":"Recovery of Pseudomonas aeruginosa from syringes of drug addicts with endocarditis.","volume":"144","author":"Rajashekaraiah","year":"1981","journal-title":"J Infect Dis"},{"key":"R35-5-20210226","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-197801000-00004","article-title":"Treatment of patients with Pseudomonas endocarditis with high-dose aminoglycoside and carbenicillin therapy.","volume":"57","author":"Reyes","year":"1978","journal-title":"Medicine (Baltimore)"},{"key":"R36-5-20210226","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/clinids\/5.2.314","article-title":"Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa.","volume":"5","author":"Reyes","year":"1983","journal-title":"Rev Infect Dis"},{"key":"R37-5-20210226","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-197305000-00001","article-title":"Pseudomonas endocarditis in the Detroit Medical Center, 1969-1972.","volume":"52","author":"Reyes","year":"1973","journal-title":"Medicine (Baltimore)"},{"key":"R38-5-20210226","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11908-008-0044-5","article-title":"Gram-negative endocarditis.","volume":"10","author":"Reyes","year":"2008","journal-title":"Curr Infect Dis"},{"key":"R39-5-20210226","first-page":"369","article-title":"Cefepime: the next generation?","volume":"17","author":"Sanders","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R40-5-20210226","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/149.2.257","article-title":"Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis.","volume":"149","author":"Tablan","year":"1984","journal-title":"J Infect Dis"},{"key":"R41-5-20210226","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000007198","article-title":"Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model.","volume":"45","author":"Tessier","year":"1999","journal-title":"Chemotherapy"},{"key":"R42-5-20210226","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/AAC.46.8.2327-2332.2002","article-title":"Comparative stability studies of antipseudomonal -lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).","volume":"46","author":"Viaene","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-5-20210226","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00005792-198605000-00006","article-title":"Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature.","volume":"65","author":"Wieland","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"R44-5-20210226","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1128\/AAC.26.5.673","article-title":"Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.","volume":"26","author":"Winston","year":"1984","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181b8bedc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:01:09Z","timestamp":1786039269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200909000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181b8bedc","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}